The DOI matches its Crossref record; 65 of the 68 references it cites were found in a registry or an index.
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Open accessAbstract
In 2012, the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) published a position statement on the management of hyperglycemia in patients with type 2 diabetes (1,2). This was needed because of an increasing array of antihyperglycemic drugs and growing uncertainty regarding their proper selection and sequence. Because of a paucity of comparative effectiveness research on long-term treatment outcomes with many of these medications, the 2012 publication was less prescriptive than prior consensus reports. We previously described the need to individualize both treatment targets and treatment strategies, with an emphasis on patient-centered care and shared decision making, and this continues to be our position, although there are now more head-to-head trials that show slight variance between agents with regard to glucose-lowering effects. Nevertheless, these differences are often small and would be unlikely to reflect any definite differential effect in an individual patient. The ADA and EASD have requested an update to the position statement incorporating new data from recent clinical trials. Between June and September of 2014, the Writing Group reconvened, including one face-to-face meeting, to discuss the changes. An entirely new statement was felt to be unnecessary. Instead, the group focused on those areas where revisions were suggested by a changing evidence base. This briefer article should therefore be read as an addendum to the previous full account (1,2). Glucose control remains a major focus in the management of patients with type 2 diabetes. However, this should always be in the context of a comprehensive cardiovascular risk factor reduction program, to include smoking cessation and the adoption of other healthy lifestyle habits, blood pressure control, lipid management with priority to statin medications, and, in some circumstances, antiplatelet therapy. Studies have conclusively determined that reducing hyperglycemia decreases the onset and progression of …
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Strong evidence supports the ef fi cacy and cost-effectiveness of nutrition therapy as a component of quality diabetes care, including its integration into the medical management of diabetes”
From Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report (2019) · cites this paper as [2]
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Self-citationDormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919
Self-citationSaxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
Scirica, B. M., Bhatt, D. L., Braunwald, E., Steg, P. G., Davidson, J., Hirshberg, B., Ohman, P., Frederich, R., Wiviott, S. D., Hoffman, E. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1307684 · Cited by 3,470
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetes Care · doi:10.2337/dc12-0413 · Cited by 3,207
Self-citationAlogliptin after acute coronary syndrome in patients with type 2 diabetes
White, W. B., Cannon, C. P., Heller, S. R., Nissen, S. E., Bergenstal, R. M., Bakris, G. L., Perez, A. T., Fleck, P. R., Mehta, C. R., Kupfer, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305889 · Cited by 2,502
Self-citationGerstein, H. C., Miller, M., & Byington, R. P. (2010) · Cited by 981
Sodium–Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes: A Systematic Review and Meta-analysis
Vasilakou, D., Karagiannis, T., Athanasiadou, E., Mainou, M., Liakos, A., Bekiari, E., Sarigianni, M., Matthews, D. R., & Tsapas, A. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-4-201308200-00007 · Cited by 911
Self-citationRisk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
Salpeter, S. R., Greyber, E., Pasternak, G. A., & Salpeter (posthumous), E. E. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002967.pub4 · Cited by 893
Inzucchi, S., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M. A., Peters, A. L., Τσάπας, Α., Wender, R. C., & Dr, M. (2013) · Diabetes Care · doi:10.2337/dc13-er02 · Cited by 805
Self-citationScirica, B. M., Braunwald, E., Raz, I., Cavender, M. A., Morrow, D. A., Jarolim, P., Udell, J. A., Mosenzon, O., Im, K., Umez-Eronini, A. A., et al. (2014) · Circulation · doi:10.1161/circulationaha.114.010389 · Cited by 725
Cefalu, W. T., Leiter, L. A., Yoon, K., Arias, P., NISKANEN, L. K., Xie, J., Balis, D. A., Canovatchel, W. J., & Meininger, G. E. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60683-2 · Cited by 723
Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes
Holman, R. R., Thorne, K. I., Farmer, A. A., Davies, M. J., Keenan, J. F., Paul, S. K., & Lévy, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa075392 · Cited by 710
Stenlöf, K., Cefalu, W. T., Kim, K., Alba, M., Usiskin, K., Tong, C., Canovatchel, W. J., & Meininger, G. E. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12054 · Cited by 613
[Management of hyperglycaemia in type 2 diabetes: a patient-centered approach].
Scheen, A. J., & Mathieu, C. (2012) · PubMed · Cited by 581
Nauck, M. A., Prato, S. D., Meier, J. J., Durán-Garcia, S., Rohwedder, K., Elze, M., & Parikh, S. J. (2011) · Diabetes Care · doi:10.2337/dc11-0606 · Cited by 535
Self-citationBuse, J. B., Bergenstal, R. M., Glass, L. C., Heilmann, C. R., Lewis, M. S., Kwan, A. Y. M., Hoogwerf, B. J., & Rosenstock, J. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-2-201101180-00300 · Cited by 506
Self-citationPancreatic safety of incretin-based drugs–FDA and EMA assessment
Egan, A. G., Blind, E., Dunder, K., de Graeff, P. A., Hummer, B. T., Bourcier, T., & Rosebraugh, C. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1314078 · Cited by 498
Schernthaner, G., Gross, J. L., Rosenstock, J., Guarisco, M., Fu, M., Yee, J., Kawaguchi, M., Canovatchel, W. J., & Meininger, G. E. (2013) · Diabetes Care · doi:10.2337/dc12-2491 · Cited by 481
SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects
Ferrannini, E., & Solini, A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.243 · Cited by 466
Self-citationRoden, M., Weng, J., Eilbracht, J., Delafont, B., Kim, G., Woerle, H. J., & Broedl, U. C. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70084-6 · Cited by 451
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
Salpeter, S. R., Greyber, E., Pasternak, G. A., & Salpeter, E. E. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002967.pub3 · Cited by 447
Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency
Lipska, K. J., Bailey, C. J., & Inzucchi, S. E. (2011) · Diabetes Care · doi:10.2337/dc10-2361 · Cited by 432
Self-citationChino, Y., Samukawa, Y., Sakai, S., Nakai, Y., Yamaguchi, J., Nakanishi, T., & Tamai, I. (2014) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1909 · Cited by 390
Individualizing Glycemic Targets in Type 2 Diabetes Mellitus: Implications of Recent Clinical Trials
Ismail‐Beigi, F., Moghissi, E. S., Tiktin, M., Hirsch, I. B., Inzucchi, S. E., & GENUTH, S. M. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-8-201104190-00007 · Cited by 388
Self-citationEng, C., Kramer, C. K., Zinman, B., & Retnakaran, R. R. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61335-0 · Cited by 381
Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment
(2014) · New England Journal of Medicine · doi:10.1056/nejmx140026 · Cited by 372
Rosenstock, J., Jelaska, A., Frappin, G., Salsali, A., Kim, G., Woerle, H. J., & Broedl, U. C. (2014) · Diabetes Care · doi:10.2337/dc13-3055 · Cited by 366
Renal sodium–glucose transport: role in diabetes mellitus and potential clinical implications
Bakris, G. L., Fonseca, V. A., Sharma, K., & Wright, E. M. (2009) · Kidney International · doi:10.1038/ki.2009.87 · Cited by 358
Neal, B. C., Perkovic, V., de Zeeuw, D., Mahaffey, K. W., Fulcher, G., Stein, P., Desai, M. G., Shaw, W. C., Jiang, J., Vercruysse, F., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.05.007 · Cited by 341
Self-citationMonami, M., Nardini, C., & Mannucci, E. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12244 · Cited by 286
Musso, G., Gambino, R., Cassader, M., & Pagano, G. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.560181 · Cited by 284
Nathan, D. M., Buse, J. B., Kahn, S. E., Krause-Steinrauf, H. J., Larkin, M., Staten, M. A., Wexler, D. J., & Lachin, J. M. (2013) · Diabetes Care · doi:10.2337/dc13-0356 · Cited by 257
Self-citationDiamant, M., Nauck, M. A., Shaginian, R. M., Malone, J. K., Cleall, S., Reaney, M. D., de Vries, D., Hoogwerf, B. J., MacConell, L., Wolffenbuttel, B. H. R., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0876 · Cited by 229
Self-citationRosenstock, J., SEMAN, L. J., Jelaska, A., Hantel, S., Pinnetti, S., Hach, T., & Woerle, H. J. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12185 · Cited by 217
Gaziano, J. M., Cincotta, A. H., O’Connor, C. M., Ezrokhi, M., Rutty, D., Ma, Z., & Scranton, R. E. (2010) · Diabetes Care · doi:10.2337/dc09-2009 · Cited by 214
Vulvovaginitis and balanitis in patients with diabetes treated with dapagliflozin
Johnsson, K. M., Ptaszynska, A., Schmitz, B., Sugg, J. E., Parikh, S. J., & List, J. F. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.04.012 · Cited by 212
Chiasson, J.-L., Gomis, R., Hanefeld, M., Josse, R. G., Karasik, A., Laakso, M., & The Stop-Niddm Trial Research Group (1998) · Diabetes Care · doi:10.2337/diacare.21.10.1720 · Cited by 182
Phung, O. J., Sobieraj, D. M., Engel, S. S., & Rajpathak, S. N. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12233 · Cited by 168
Colhoun, H. M., Livingstone, S. J., Looker, H. C., Morris, A. D., Wild, S. H., Lindsay, R. S., Reed, C., Donnan, P. T., Guthrie, B., Leese, G., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2668-0 · Cited by 152
Balena, R., Hensley, I. E., Miller, S., & Barnett, A. H. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12025 · Cited by 143
Nyirjesy, P., Sobel, J. D., Fung, A., Mayer, C., Capuano, G. A., Ways, K., & Usiskin, K. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.890925 · Cited by 139
Weir, M. R., Kline, I., Xie, J., Edwards, R., & Usiskin, K. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.919907 · Cited by 120
Cardiovascular safety of the dipetidyl peptidase‐4 inhibitor alogliptin in type 2 diabetes mellitus
White, W. B., Pratley, R. E., Fleck, P. R., Munsaka, M., Hisada, M., Wilson, C., & Menon, V. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12093 · Cited by 117
Davidson, M. B., Raskin, P., Tanenberg, R. J., Vlajnic, A., & Hollander, P. (2011) · Endocrine Practice · doi:10.4158/ep10323.or · Cited by 107
Goring, S. M., Hawkins, N., Wygant, G. D., Roudaut, M., Townsend, R., Wood, I., & Barnett, A. H. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12239 · Cited by 98
Metformin: The Safest Hypoglycaemic Agent in Chronic Kidney Disease?
Nye, H. J., & Herrington, W. G. (2011) · Nephron Clinical Practice · doi:10.1159/000323739 · Cited by 92
Lane, W. S., Weinrib, S. L., Rappaport, J. M., & Hale, C. B. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12286 · Cited by 91
Bosi, E., Ellis, G. C., Wilson, C. A., & Fleck, P. R. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01463.x · Cited by 88
Pioglitazone and bladder cancer: a propensity score matched cohort study
Wei, L., MacDonald, T. M., & Mackenzie, I. S. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04325.x · Cited by 86
Hawa, M. I., Buchan, A. P., Ola, T. O., Wun, C. C., DeMicco, D. A., Bao, W., Betteridge, D. J., Durrington, P. N., Fuller, J., Neil, H. A. W., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2383 · Cited by 85
Zampetti, S., Campagna, G., Tiberti, C., Songini, M., Arpi, M. L., Simone, G. D., Cossu, E., Cocco, L., Osborn, J., Bosi, E., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0342 · Cited by 80
Review: Metformin: Potential benefits and use in chronic kidney disease
Pilmore, H. (2010) · Nephrology · doi:10.1111/j.1440-1797.2010.01328.x · Cited by 69
Shah, P., Mudaliar, S. R. D., Chang, A. R., Aroda, V. R., André, M., Burke, P., & Henry, R. R. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01370.x · Cited by 55
Davidson, M. B., Navar, M. D., Echeverry, D., & Duran, P. A. (2009) · Diabetes Care · doi:10.2337/dc09-1490 · Cited by 53
Groop, P., Prato, S. D., Taskinen, M., Owens, D. R., Gong, Y., Crowe, S., Patel, S., von Eynatten, M., & Woerle, H. J. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12281 · Cited by 51
Charbonnel, B. H., DeFronzo, R. A., Davidson, J. A., Schmitz, O., Birkeland, K. I., Pīrāgs, V., Scheen, A. J., & on behalf of the PROactive investigators (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1974 · Cited by 51
Lixisenatide plus basal insulin in patients with type 2 diabetes mellitus: a meta-analysis
Charbonnel, B. H., Bertolini, M., Tinahones, F. J., Puig‐Domingo, M., & Davies, M. J. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.07.007 · Cited by 48
Lu, W. R., Defilippi, J. L., & Braun, A. (2013) · Annals of Pharmacotherapy · doi:10.1177/1060028013505428 · Cited by 45
Pioglitazone use and the risk of bladder cancer
Kuo, H., Tiao, M., Ho, S., & Yang, C. (2013) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2013.09.011 · Cited by 33
Balaji, V., Seshiah, V., Ashtalakshmi, G., Ramanan, S., & Janarthinakani, M. (2014) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.131223 · Cited by 30
Cited by
Sorted by citations
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518
Self-citationDiMeglio, L. A., Evans-Molina, C., & Oram, R. A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31320-5 · Cited by 1,561
Rangaswami, J., Bhalla, V., Blair, J. E., Chang, T. I., Costa, S. P., Lentine, K. L., Lerma, E. V., Mezue, K. N., Molitch, M. E., Müllens, W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000664 · Cited by 1,535
Metadata
- Authors
- Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R.
- Affiliations
- Yale New Haven Hospital (US)
- Park Nicollet Health Services (US)
- University of North Carolina at Chapel Hill (US)
- Diabetes Center/Department of Internal Medicine, VU University Medical Center, Amsterdam, the Netherlands
- University of Pisa (IT)
- Diabeteszentrum Bad Lauterberg (DE)
- University of Southern California (US)
- Second Medical Department, Aristotle University Thessaloniki, Thessaloniki, Greece
- American Cancer Society (US)
- Churchill Hospital (GB)
- Corresponding author
- Inzucchi, Silvio E.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2014-12-13
- Volume
- 38
- Issue
- 1
- Pages
- 140-149
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2160088494
- Cited by
- 3,066
- References
- 68
- Citations by year
- 2026: 52 · 2025: 84 · 2024: 96 · 2023: 135 · 2022: 138 · 2021: 142 · 2020: 202 · 2019: 313 · 2018: 482 · 2017: 545 · 2016: 540 · 2015: 325 · 2014: 7
- FWCI
- 380.40
- Type
- journal article
- Language
- en
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- other-oa
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Massachusetts General Hospital
- Yale University
- Kaiser Permanente
- F. Hoffmann-La Roche
- Case Western Reserve University
- School of Medicine, Case Western Reserve University
- Intarcia Therapeutics
- National Institute for Health and Care Research
- University of Sydney
- Universiteit van Amsterdam
- University of Toronto
- Novo Nordisk
- Uniwersytet Łódzki
- European Association for the Study of Diabetes
- Université de Nantes
- Servier
- Lilly Deutschland
- University of Ioannina
- School of Medicine, University of Kansas
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes, hyperglycemia management, antidiabetic drugs, patient-centered care, shared decision-making, glucose-lowering agents, cardiovascular risk reduction, smoking cessation, blood pressure control, lipid control, statins, antiplatelet therapy, lifestyle modification
- MeSH terms
- Clinical Trials as Topic, Diabetes Mellitus, Type 2, Drug Combinations, Humans, Hyperglycemia, Metformin, United States, Disease Management, Glycemic Index, Thiazolidinediones, Dipeptidyl-Peptidase IV Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
